Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts
VV Sahasrabuddhe, P Luhn, N Wentzensen - Future microbiology, 2011 - Taylor & Francis
While organized screening programs in industrialized countries have significantly reduced
cervical cancer incidence, cytology-based screening has several limitations. Equivocal or …
cervical cancer incidence, cytology-based screening has several limitations. Equivocal or …
Histology of cervical intraepithelial neoplasia and the role of biomarkers
CM Martin, JJ O'Leary - Best practice & research Clinical obstetrics & …, 2011 - Elsevier
Accurate histological grading of cervical intraepithelial neoplasia (CIN) lesions is important
for clinical management of patients, because CIN1 and CIN2 and 3 lesions are treated …
for clinical management of patients, because CIN1 and CIN2 and 3 lesions are treated …
Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2–3 in follow up biopsies and spontaneous …
IT Ovestad, U Vennestrøm, L Andersen… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: Different Human Papilloma Virus (HPV) tests are currently used. An integrated
comparison of the Amplicor, Cobas4800, PreTect HPV-Proofer and APTIMA HPV tests has …
comparison of the Amplicor, Cobas4800, PreTect HPV-Proofer and APTIMA HPV tests has …
Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology
HT Nishino, RH Tambouret, DC Wilbur - Cancer cytopathology, 2011 - Wiley Online Library
High‐risk human papillomavirus (hrHPV) testing has become an integral component of
cervical cancer screening, given that persistent infection with hrHPV was recognized as a …
cervical cancer screening, given that persistent infection with hrHPV was recognized as a …
[PDF][PDF] Clinical performance of human papillomavirus E6, E7 mRNA flow cytometric assay compared to human papillomavirus DNA typing
OBJECTIVE: To use flow cytometry to screen cervical samples for the overexpression of
human papillomavirus (HPV) E6 and E7 mRNA and compare the performance of this assay …
human papillomavirus (HPV) E6 and E7 mRNA and compare the performance of this assay …
Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia
A Tropé, CM Jonassen, KD Sjøborg, M Nygård… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: To evaluate testing for high-risk human papillomavirus (HR HPV) E6/E7 mRNA
transcripts 6months after conisation for cervical intraepithelial neoplasia grade 2 or worse …
transcripts 6months after conisation for cervical intraepithelial neoplasia grade 2 or worse …
Molecular diagnosis of HPV infections
N Wentzensen - Der Pathologe, 2011 - Springer
Karzinogene humane Papillomviren (HPV) sind die Auslöser des Zervixkarzinoms und
anderer anogenitaler Karzinome. Große randomisierte Studien haben gezeigt, dass HPV …
anderer anogenitaler Karzinome. Große randomisierte Studien haben gezeigt, dass HPV …
Détection moléculaire des papillomavirus humains dans les tissus sains et tumoraux des cancers de l'oropharynx
B Dessaigne - 2011 - policycommons.net
Les Papillomavirus Humains (HPV) oncogènes, principalement l'HPV de type 16, sont
associés aux cancers de l'oropharynx. La fréquence exacte de cette association est mal …
associés aux cancers de l'oropharynx. La fréquence exacte de cette association est mal …
[引用][C] Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2–3 in follow up biopsies and …
A Malpica, W Feng, F Voorhorst, EAM Janssen… - 2011